|
FY2022
12 months to Jan 31, 2022
|
FY2021
12 months to Jan 31, 2021
|
FY2020
12 months to Jan 31, 2020
|
FY2019
12 months to Jan 31, 2019
|
FY2018
12 months to Jan 31, 2018
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss attributable to Coupa Software Incorporated | |||||
| Net loss and adjustment attributable to redeemable non-controlling interests (Note 3) | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of premium on marketable securities, net | |||||
| Amortization of deferred commissions | |||||
| Amortization of debt discount and issuance costs | |||||
| Stock-based compensation | |||||
| Loss (gain) on conversion of convertible senior notes | |||||
| Repayments of convertible senior notes attributable to debt discount (Note 10) | |||||
| Other | |||||
| Changes in operating assets and liabilities net of effects from acquisitions: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Deferred commissions | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of marketable securities | |||||
| Maturities of marketable securities | |||||
| Sale of marketable securities | |||||
| Acquisitions, net of cash acquired | |||||
| Purchases of other investments | |||||
| Purchases of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Investment from redeemable non-controlling interests | |||||
| Proceeds from issuance of convertible senior notes, net of issuance costs | |||||
| Purchase of capped calls | |||||
| Repayments of convertible senior notes | |||||
| Proceeds from the exercise of common stock options | |||||
| Proceeds from issuance of common stock for employee stock purchase plan | |||||
| Cash and cash equivalents | |||||
| Net cash provided by financing activities | |||||
| Effects of foreign currency exchange rates on cash, cash equivalents, and restricted cash | |||||
| Net increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of year | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets | |||||
| Cash and cash equivalents | |||||
| Restricted cash included in other assets | |||||
| Total cash, cash equivalents, and restricted cash | |||||
| Supplemental disclosure of cash flow data | |||||
| Cash paid for income taxes | |||||
| Cash paid for interest | |||||
| Supplemental disclosure of non-cash investing and financing activities | |||||
| Issuance of common stock in connection with acquisitions | |||||
| Vesting of early exercised stock options | |||||
| Property and equipment included in accounts payable and accrued expenses and other current liabilities | |||||
Loading...